Thursday, November 19, 2026
News

Health Ministry proposes amendment to drug rules to bring antimicrobials under central oversight

SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | November 19, 2026 11:41:22 AM IST
The Union Ministry of Health and Family Welfare has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, to include 'antimicrobials' in the definition of 'New Drug' under Rule 2(1)(w)(v).

The proposed amendment has been introduced through a draft Gazette Notification G.S.R. 983 (E) dated November 6.

Antimicrobial resistance (AMR) is a major global public health concern and a priority requiring coordinated action. The G20 New Delhi Leaders Declaration also underscored the need to address antimicrobial resistance through a One Health approach.

The proposed amendment has been initiated in view of concerns regarding the grant of manufacturing licences for antimicrobial products without adequate regulatory scrutiny, including the requirement for studies such as bioavailability/bioequivalence and stability studies.

The absence of such assessments may affect the quality, safety and efficacy of antimicrobial products. Substandard or ineffective antimicrobials can contribute to the development and spread of antimicrobial resistance, posing risks to patient safety.

The proposed amendment seeks to bring antimicrobials within the regulatory framework applicable to new drugs under the New Drugs and Clinical Trials Rules, 2019.

Accordingly, manufacturers would be required to obtain permission from the Central Licensing Authority (CLA) before applying for a manufacturing licence from the concerned State Licensing Authority (SLA).

This is expected to strengthen central regulatory oversight and help ensure the quality, safety and efficacy of antimicrobial products.

The draft notification has been issued to invite objections and suggestions from stakeholders and members of the public before the proposed amendment is considered for finalisation by the Central Government.

Objections and suggestions, if any, may be submitted to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Government of India, U-6, Work HallC Wing, First Floor, Kartavya Bhawan-1, New Delhi110001, or through email at drugsdiv-mohfwatgovdotin, within 30 days from the date on which copies of the Gazette containing the draft rules are made available to the public. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
'Humanitarian Assistance and Disaster Re...
Odisha evacuates over 72,000 people from...
Delhi CM Rekha Gupta leads Yamuna cleanl...
Cyclone Akvan to cross Andhra Pradesh-Od...
'Other countries keen to learn about our...
India playing a whole new game: PM Mod...
More...    
 
 Top Stories
Trump-Xi-Putin trilateral talks beg... 
Kane Williamson reveals his picks f... 
US lawmakers urge trump to raise wr... 
Baloch Voice for Justice urges fore... 
Star Power Structural Projects Earn... 
"24% candidates from single centre ... 
Punjab: Upstream water flow reduced... 
"Major powers bear special responsi...